Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies
Status:
Completed
Trial end date:
2019-04-12
Target enrollment:
Participant gender:
Summary
This is a phase I, open-label study to assess the safety, tolerability, pharmacokinetics and
preliminary anti-tumor activity of AZD9150 monotherapy and AZD9150 in combination with
durvalumab in Japanese patients with advanced solid malignancies.